Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Feb;91(2):416-9.
doi: 10.1172/JCI116216.

Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon

Affiliations

Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon

R T Means Jr et al. J Clin Invest. 1993 Feb.

Abstract

We have previously reported that inhibition of human CFU-erythroid (E) colony formation by tumor necrosis factor (TNF) is an indirect effect mediated by a soluble factor released from a fraction of marrow accessory cells which are predominantly stromal elements (Means, R. T., Jr., E. N. Dessypris, and S. B. Krantz. 1990. J. Clin. Invest. 86:538-541). Further studies reported here identify a mediator of this effect. The inhibitory effect of recombinant TNF on marrow CFU-E is ablated by neutralizing antibodies to human beta IFN, but not by antibodies to gamma IFN or IL-1. Anti-beta IFN also neutralizes the inhibitory effect of conditioned medium prepared from marrow cells exposed to TNF. Human beta IFN inhibits colony formation by unpurified marrow CFU-E as well as highly purified CFU-E generated from peripheral blood progenitors, and limiting dilution analysis shows that this is a direct inhibitory effect. TNF has been implicated in the pathogenesis of the anemia of chronic diseases since blood TNF levels are elevated in many patients with this syndrome, and since exposure to TNF produces a similar anemia in either humans or mice. The present study demonstrates that beta IFN is a required mediator of this inhibitory effect on erythropoiesis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Semin Hematol. 1983 Apr;20(2):61-80 - PubMed
    1. J Clin Invest. 1989 May;83(5):1701-9 - PubMed
    1. Clin Haematol. 1984 Jun;13(2):371-91 - PubMed
    1. Blood. 1985 May;65(5):1105-11 - PubMed
    1. Blood. 1989 Jul;74(1):130-8 - PubMed

Publication types

MeSH terms